Prediction models for breast cancer prognosis among Asian women

Robust and reliable prognosis prediction models have not been developed and validated for Asian patients with breast cancer, a rapidly growing yet understudied population in the United States.

[1]  Gretchen L. Gierach,et al.  Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women , 2020, JAMA network open.

[2]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[3]  C. Friedenreich,et al.  Physical Activity in Cancer Prevention and Survival: A Systematic Review , 2019, Medicine and science in sports and exercise.

[4]  S. Tin Tin,et al.  Prognostic models for breast cancer: a systematic review , 2019, BMC Cancer.

[5]  J. Wyatt,et al.  Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data , 2018, British Journal of Cancer.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  Greta M. Massetti,et al.  Weight management and physical activity throughout the cancer care continuum , 2017, CA: a cancer journal for clinicians.

[8]  Hua Zhao,et al.  Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data , 2017, Journal of the National Cancer Institute.

[9]  P. Goodwin,et al.  Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Muss,et al.  Internet tools to enhance breast cancer care , 2016, npj Breast Cancer.

[11]  James E. Helmreich.  Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis (2nd Edition) , 2016 .

[12]  X. Shu,et al.  Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women. , 2015, The American journal of clinical nutrition.

[13]  A. McTiernan,et al.  Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Yanhua Rao,et al.  Association between Soy Isoflavone Intake and Breast Cancer Risk for Pre- and Post-Menopausal Women: A Meta-Analysis of Epidemiological Studies , 2014, PloS one.

[15]  J. Coffey,et al.  Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. , 2013, Clinical breast cancer.

[16]  S. Cross,et al.  PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 , 2012, British Journal of Cancer.

[17]  H. Verkooijen,et al.  Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. , 2012, European journal of cancer.

[18]  M. J. van de Vijver,et al.  UvA-DARE ( Digital Academic Repository ) External Validation of Adjuvant ! Online Breast Cancer Prognosis Tool Prioritising Recommendations for Improvement , 2012 .

[19]  David R Bassett,et al.  2011 Compendium of Physical Activities: a second update of codes and MET values. , 2011, Medicine and science in sports and exercise.

[20]  P. V. van Diest,et al.  In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Coory,et al.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[22]  X. Shu,et al.  Obesity and weight change in relation to breast cancer survival , 2010, Breast Cancer Research and Treatment.

[23]  Carlos Caldas,et al.  PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer , 2010, Breast Cancer Research.

[24]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[25]  S. Mook,et al.  Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. , 2009, The Lancet. Oncology.

[26]  A. Harris,et al.  An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom , 2009, British Journal of Cancer.

[27]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[28]  G. Ball,et al.  Reading the prognosis of the individual with breast cancer. , 2007, European journal of cancer.

[29]  A. Carmichael,et al.  Obesity and prognosis of breast cancer , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[30]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[31]  Karen A Gelmon,et al.  Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  A. McTiernan,et al.  Weight loss in breast cancer patient management. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  S. Akashi-Tanaka,et al.  Validation and problems of St-Gallen recommendations of adjuvant therapy for node-negative invasive breast cancer in Japanese patients. , 2001, Japanese journal of clinical oncology.

[35]  P. Ravdin,et al.  Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  K. Covinsky,et al.  Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.

[37]  E. Winer,et al.  Weight gain in women diagnosed with breast cancer. , 1997, Journal of the American Dietetic Association.

[38]  Lawrence T. Post,et al.  American College of Surgeons , 2020, Definitions.

[39]  R. Kraft Rovere,et al.  Adjuvant! Online: mind the gap! , 2013, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[40]  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.

[41]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[42]  Sten Thorstenson,et al.  Applying the Nottingham Prognostic Index to a Swedish breast cancer population , 2004, Breast Cancer Research and Treatment.

[43]  C. Axelsson,et al.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG) , 2004, Breast Cancer Research and Treatment.

[44]  B. Hoffman,et al.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.